[Cryoglobulins and circulating immune complexes in rheumatoid arthritis. Clinical and biological correlations]. 1979

P Segond, and L Grangeot-Keros, and D Sallière, and L Gutman, and C Lhéritier, and M Bisson, and P Massias

We studied circulating immune complexes using a test involving the precipitation of these complexes with polyethylene glycol 6000 at 2.5 percent, and characterization of the Clq bound in vivo to immunoglobulins in the serum of 126 healthy subjects, 95 hospitalized controls and 181 patients suffering from rheumatoid arthritis (RP). Likewise, the RP benefited from a study of cryoglobulins (CG). The PEG-Clq proved positive (PEG +) in 7 per cent of the healthy controls, 25 per cent in the seronegative RP. ThePEG & RP have a level of proteins, gammaglobulins, IgM and IgG that is higher than in patients in whom the test is negative. On the other hand, they have a lower level of C4. One CG was detected in 43 patients who were all PEG +. The level of CG is proportionate to the intensity of the articular inflammation, the sedimentation rate, the level of seric iron and that of hemoglobin. The composition of the precipitins obtained by activity of the PEG is very close to that of the CG.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D008297 Male Males
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003172 Complement C1 The first complement component to act in the activation of CLASSICAL COMPLEMENT PATHWAY. It is a calcium-dependent trimolecular complex made up of three subcomponents: COMPLEMENT C1Q; COMPLEMENT C1R; and COMPLEMENT C1S at 1:2:2 ratios. When the intact C1 binds to at least two antibodies (involving C1q), C1r and C1s are sequentially activated, leading to subsequent steps in the cascade of COMPLEMENT ACTIVATION. C1 Complement,Complement 1,Complement Component 1,C1, Complement,Complement, C1,Component 1, Complement
D003450 Cryoglobulins Abnormal immunoglobulins, especially IGG or IGM, that precipitate spontaneously when SERUM is cooled below 37 degrees Celsius. It is characteristic of CRYOGLOBULINEMIA. Cryoglobulin,Cryoprotein,Cryoproteins
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Segond, and L Grangeot-Keros, and D Sallière, and L Gutman, and C Lhéritier, and M Bisson, and P Massias
January 1987, Revista do Hospital das Clinicas,
P Segond, and L Grangeot-Keros, and D Sallière, and L Gutman, and C Lhéritier, and M Bisson, and P Massias
October 1985, The Journal of rheumatology,
P Segond, and L Grangeot-Keros, and D Sallière, and L Gutman, and C Lhéritier, and M Bisson, and P Massias
April 1985, Revue du rhumatisme et des maladies osteo-articulaires,
P Segond, and L Grangeot-Keros, and D Sallière, and L Gutman, and C Lhéritier, and M Bisson, and P Massias
January 1981, Voprosy revmatizma,
P Segond, and L Grangeot-Keros, and D Sallière, and L Gutman, and C Lhéritier, and M Bisson, and P Massias
June 1987, The Journal of rheumatology,
P Segond, and L Grangeot-Keros, and D Sallière, and L Gutman, and C Lhéritier, and M Bisson, and P Massias
October 1983, Ryumachi. [Rheumatism],
P Segond, and L Grangeot-Keros, and D Sallière, and L Gutman, and C Lhéritier, and M Bisson, and P Massias
January 1984, Annales de biologie clinique,
P Segond, and L Grangeot-Keros, and D Sallière, and L Gutman, and C Lhéritier, and M Bisson, and P Massias
January 1990, Clinical and experimental rheumatology,
P Segond, and L Grangeot-Keros, and D Sallière, and L Gutman, and C Lhéritier, and M Bisson, and P Massias
January 1978, Rheumatology and rehabilitation,
P Segond, and L Grangeot-Keros, and D Sallière, and L Gutman, and C Lhéritier, and M Bisson, and P Massias
August 1982, Annals of the rheumatic diseases,
Copied contents to your clipboard!